CLINICOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH SYNCHRONOUS PRIMARY OVARIAN AND ENDOMETRIAL CANCERS

  • Samreen Chaudary Radiation Oncology department, SKMCH&RC, Lahore
  • Tabina Sadaf SKMCH&RC, Lahore
  • Sumera Butt SKMCH&RC Lahore
  • Aamir Ali Syed SKMCH&RC Lahore
  • Neelam Siddiqui Medical Oncology Department, SKMCH&RC

Abstract

Purpose: Synchronous primary endometrial and ovarian cancers are infrequent. The objective of this study is to evaluate clinicopathological characteristics of synchronous endometrial and ovarian cancers treated in our institution.

Materials and Methods: The clinicopathological characteristics of 12 patients with synchronous ovarian and endometrial cancers treated at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, from July 2005 to July 2015, were reviewed retrospectively in depth from hospital database. The WHO committee classification was used for the histologic determination and staged based on International Federation of Gynaecology and Obstetrics (FIGO) staging.

Results: The median age at the time of diagnosis was 50 years (range 23–66 years). The incidence of synchronous primary endometrial and ovarian cancers was 2.01% in patients with endometrial cancer. A total of seven patients were menopausal (58%) and eight patients were nulliparous (66%); the median body mass index (BMI) was 29 kg/m2 (range, 20–38). Abnormal uterine bleeding was the most common presenting symptom. According to FIGO stage, 10 cases of endometrial were Stage I/II (84%) and two cases were Stage III (16%). Of the ovarian cancers, nine cases were Stage I/II (83.3%) and two cases were Stage III (16.7%). Endometrial cancer was the main pathological type in uterine carcinoma (86%) followed by serous carcinoma (14%), and similarly, for ovarian cancer, endometrial was the most common pathology (67%) followed by serous/clear cell (16%) and mucinous (16.7%). Most endometrial and ovarian primaries in our series were Grade I and II tumours, 83% and 66%, respectively. 8 patients (66%) had similar histology in both primaries. All patients underwent surgical intervention. Only one patient did not receive any post-operative adjuvant therapy. 10 patients received platinum-based adjuvant chemotherapy and six patients received adjuvant radiotherapy.

Conclusion: Synchronous primary endometrial and ovarian cancers are infrequent and distinct set of patients. Abnormal per vaginal bleed was the most common symptom which helped in early detection. Majority of the patients belong to concordant endometrial histology, low grade, had younger age and high BMI. Treatment should be tailored to the stage, histology and grade of the individual tumours.

Key words: Endometrial cancer, ovarian cancer, synchronous tumours

References

Ayhan A, Yalçin OT, Tuncer ZS, et al. Synchronous primary malignancies of the female genital tract. Eur J Obstet Gynecol Reprod Biol 1992;45:63-6.

Tong SY, Lee YS, Park JS, et al. Clinical analysis of synchronous primary neoplasms of the female reproductive tract. Eur J Obstet Gynecol Reprod Biol 2008;136:78-82.

Eisner RF, Nieberg RK, Berek JS. Synchronous primary neoplasms of the female reproductive tract. Gynecol Oncol 1989;33:335-9.

Chiang YC, Chen CA, Huang CY, et al. Synchronous primary cancers of the endometrium and ovary. Int J Gynecol Cancer 2008;18:159-64.

Woodruff JD, Solomon D, Sullivant H. Multifocal disease in the upper genital canal. Obstet Gynecol 1985;65:695-8. 6. Lauchlan SC. The secondary müllerian system. Obstet Gynecol Surv 1972;27:133-46.

Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: A single institution review of 84 cases. Gynecol Oncol 2004;94:456-62.

Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Atlas of Tumor Pathology. Vol. 189. Washington, DC: Armed Forces Institute of Pathology; 1998. p. 145.

Annegers JF, Malkasian GD Jr. Patterns of other neoplasia in patients with endometrial carcinoma. Cancer 1981;48:856-9. 10. Czernobilsky B, Silverman BD, Mikuta JJ. Endometrioid carcinoma of the ovary. Cancer 1970;26:1141-52.

Klemi KJ, Gronoos M. Endometrioid carcinoma of the ovary. A clinicopathological histochemical, and electronmicroscopic study. Obstet Gynecol 1979;53:572-9. 12. Kottmeier HL. The diagnosis and treatment of ovarian malignancies. Arq Patol 1965;37:51-64.

WalshC,HolschneiderC,HoangY,etal.Coexistingovarian malignancy in young women with endometrial cancer. Obstet Gynecol 2005;106:693-9.

Herrinton LJ, Voigt LF, Weiss NS, et al. Risk factors for synchronous primary endometrial and ovarian cancers. Ann Epidemiol 2001;11:529-33.

Nishimura N, Hachisuga T, Yokoyama M, et al. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary. J Obstet Gynaecol Res 2005;31:120-6.

Zaino R, Whitney C, Brady MF, et al. Simultaneously detected endometrial and ovarian carcinomas-a prospective clinicopathologic study of 74 cases: A gynecologic oncology group study. Gynecol Oncol 2001;83:355-62.

Published
2016-08-31
How to Cite
1.
Chaudary S, Sadaf T, Butt S, Syed AA, Siddiqui N. CLINICOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH SYNCHRONOUS PRIMARY OVARIAN AND ENDOMETRIAL CANCERS. J Cancer Allied Spec [Internet]. 2016Aug.31 [cited 2020Aug.15];2(2). Available from: https://journals.sfu.ca/jcas/index.php/jcas/article/view/71
Section
Original Research Article